PJWM
JAZZ icon

Philip James Wealth Mangement’s Jazz Pharmaceuticals JAZZ Stock Holding History

Philip James Wealth Mangement’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.92M Sell
15,459
-477
-3% -$83.4K 0.34% 57
2025
Q4 		$2.71M Sell
15,936
-96
-0.6% -$14.7K 0.31% 61
2025
Q3 		$2.11M Buy
16,032
+235
+1% +$28.2K 0.25% 67
2025
Q2 		$1.68M Buy
15,797
+4,675
+42% +$508K 0.21% 72
2025
Q1 		$1.38M Buy
11,122
+463
+4% +$60.4K 0.17% 74
2024
Q4 		$1.31M Buy
10,659
+3,205
+43% +$378K 0.17% 75
2024
Q3 		$830K Buy
+7,454
New +$817K 0.1% 81

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Philip James Wealth Mangement's JAZZ Position: Q1 2026 in Review

Philip James Wealth Mangement reduced its Jazz Pharmaceuticals (JAZZ) stake by 3% in Q1 2026, selling an estimated $83.4K and leaving 15,459 shares worth $2.92M. The position accounts for 0.34% of the portfolio, ranked #57.

Philip James Wealth Mangement first reported a position in JAZZ in Q3 2024 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Philip James Wealth Mangement held 15,459 shares of Jazz Pharmaceuticals worth $2.92M as of Q1 2026.
  • Philip James Wealth Mangement sold 477 Jazz Pharmaceuticals shares in Q1 2026, an estimated $83.4K.
  • Jazz Pharmaceuticals made up 0.34% of Philip James Wealth Mangement's portfolio in Q1 2026, its #57 holding.
  • Philip James Wealth Mangement first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Philip James Wealth Mangement's 13F filing for Q1 2026, filed 28 Apr 2026.